Ahead of the initial share sale opening for public subscription, the unlisted shares of Anthem Biosciences were trading at ...

JM Financial Limited is acting as the book-running lead manager to the issue, and KFin Technologies Limited is the registrar.

Ahead of the issue launch, Anthem Biosciences has raised ₹1,016 crore from 60 institutional investors via its anchor book on ...

The mainboard issue of the research-driven drug manufacturer opens for subscription on July 14. Here's everything you must ...

Anthem Biosciences IPO opened for subscription on July 14, 2025, with a total issue size of Rs 3,395 crore via offer for sale. Priced in the Rs 540–570 band, ...

The offer-for-sale (OFS), priced between ₹ 540 and ₹ 570 per share, marks a key milestone for the company, which has ...

Anthem Biosciences raised ₹1,016.02 crore from 60 institutional investors ahead of its IPO launch on July 14. The offering, ...

According to InvestorGain, the grey market premium (GMP) for the Anthem Biosciences IPO stood at Rs 107 as of 9:31 a.m. on ...

Anthem Biosciences IPO opens with ₹3,395 crore offer, price band set at ₹540-570 per share, targeting global pharmaceutical market.

As investors await the opening of Anthem Biosciences IPO, here are the key strengths and risks outlined in its Red Herring ...

Anthem Biosciences launched its IPO on July 14, featuring an offer for sale of Rs 3,395 crore. The Bengaluru-based CRDMO, ...